| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/24/2006 | CA2205757C Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii) |
| 01/24/2006 | CA2191832C Block oligomers containing 2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 01/24/2006 | CA2166415C Acylated aminophenylsulfonylureas; preparation and use as herbicides and plant growth regulators |
| 01/24/2006 | CA2123093C Sulfonamide herbicides |
| 01/19/2006 | WO2006007540A2 Piperidine derivatives as nk1 antagonists |
| 01/19/2006 | WO2006006741A1 Fused benzamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 01/19/2006 | WO2006006573A1 Filter and cyanine compound |
| 01/19/2006 | WO2006006184A2 A process for the manufacturing of loratadine and its intermediates |
| 01/19/2006 | WO2006005955A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/19/2006 | WO2006005951A1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
| 01/19/2006 | WO2006005918A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005914A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | WO2006005571A1 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi |
| 01/19/2006 | WO2006005444A1 Cationic metal complexes for use as light-absorbing compounds in the information layer of optical data carriers |
| 01/19/2006 | WO2005113514A3 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems |
| 01/19/2006 | WO2005105785A3 Indole derivatives for treatment of obesity |
| 01/19/2006 | WO2005097746A3 2-propene-1-ones as hsp 70 inducers |
| 01/19/2006 | WO2005095357A3 Pyrimidine derivatives and methods of treatment related to the use thereof |
| 01/19/2006 | WO2005075458A8 Pyrimidine derivatives as orexin receptors antagonists |
| 01/19/2006 | WO2005042514A3 Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound |
| 01/19/2006 | WO2005030130A3 Isoquinoline potassium channel inhibitors |
| 01/19/2006 | WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014817 CCK-1 receptor modulators |
| 01/19/2006 | US20060014815 Process for making pyrazole compounds |
| 01/19/2006 | US20060014808 Novel anthranilamide insecticides |
| 01/19/2006 | US20060014804 Cyanoguanidine prodrugs |
| 01/19/2006 | US20060014799 of isomeric ratios omeprazole mixtures |
| 01/19/2006 | US20060014798 Forming compounds with oxidation using hydrogen peroxide to form sulfur oxide for antisecretory agents of gastric juice |
| 01/19/2006 | US20060014795 S-(-) -amlodipine nicotinate and process for the preparation thereof |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014789 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014783 Sulfonylamino-acetic acid derivatives |
| 01/19/2006 | US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060014742 Amide derivative |
| 01/19/2006 | US20060014708 2,6-Diaminopyridine derivatives |
| 01/19/2006 | US20060010618 Use of an extract of Myrsine africana in oxidation dyeing for dyeing keratin fibres |
| 01/19/2006 | DE19748440B4 6,7-Difluor-1,2,3,4-tetrahydronaphthalin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen, diese enthaltende Flüssigkristallmischungen sowie ferroelektrische Schalt- und/oder Anzeigevorrichtungen 6,7-difluoro-1,2,3,4-tetrahydronaphthalene derivatives and their use in liquid crystalline mixtures, liquid crystal mixtures containing them, as well as ferroelectric switching and / or display devices |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2574002A1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
| 01/19/2006 | CA2573380A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/19/2006 | CA2571824A1 Mitotic kinesin inhibitors |
| 01/19/2006 | CA2571756A1 2, 4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571748A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/18/2006 | EP1616864A1 Quinoxaline derivatives, and organic semiconductor devices, electroluminescent devices and electronic appliances, made by using the derivatives |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1615914A2 Cgrp receptor antagonists |
| 01/18/2006 | EP1615913A2 Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| 01/18/2006 | EP1615912A1 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents |
| 01/18/2006 | EP1615911A1 5-hydroxyindoles with n-oxide groups and use thereof as a phosphodiesterase 4 inhibitor |
| 01/18/2006 | EP1615910A1 Processes for the preparation of n-((((pyridinyloxy)-phenylamino)quinazolinyl)-allyl)acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| 01/18/2006 | EP1615909A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators |
| 01/18/2006 | EP1615896A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | EP1615895A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 01/18/2006 | EP1615894A2 3-azabicyclo 3.2.1 octane derivatives |
| 01/18/2006 | EP1615890A1 Piperidine derivatives as renin inhibitors for the treatment of hypertension |
| 01/18/2006 | EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/18/2006 | EP1615643A1 4-phenyl-piperidine compounds and their use as modulators of opioid receptors |
| 01/18/2006 | EP1615637A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 01/18/2006 | EP1615633A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/18/2006 | EP1615613A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1417204B1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1292590B1 Admantane derivatives |
| 01/18/2006 | EP1255733B1 Farnesyl transferase inhibitors |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723208A Magnesium salt of imidazole derivative |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723199A 1,4-disubstituted piperidine derivatives and their use as 11-beta hsd1 inhibitors |
| 01/18/2006 | CN1723198A Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1721498A Fluorescent maleimides and uses thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/18/2006 | CN1720916A Rapidly decomposing administrable form for releasing active ingredient in oral cavity or bodily cavity |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237054C Insecticidal and acaricidal agents |
| 01/18/2006 | CN1237052C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
| 01/17/2006 | US6987185 Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine-carboxylate-recemate |